COMMUNIQUÉS West-GlobeNewswire

Foamix Reports Fiscal Year 2017 Financial Results and Provides Corporate Update
28/02/2018
Long Term Open Label Clinical Results Confirm That FMX101 Appears to be Safe and Well Tolerated; Continued Improvement of Treatment Effect Demonstrated at 52 Weeks Conference Call and Webcast on Wednesday, February 28, [...]
TRHC’s Coding School Accepting Applications for New Veterans Scholarship
28/02/2018
MOUNT PLEASANT, S.C., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (“TRHC”) (NASDAQ: TRHC ) announced today that its code school, JRS Coding School, in Mount Pleasant, SC, is now accepting applications for [...]
Sharecare Co-Founder Dr. Mehmet Oz to Present at The Conference Board’s 18th Annual Employee Health Care Conference in New York
28/02/2018
ATLANTA, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company helping people manage all their health in one place, today announced that its co-founder, Dr. Mehmet Oz, will be featured during a special [...]
Premier Biomedical Inc. Searching For Development Partner To Advance Patent Pending Technology
28/02/2018
Jackson Center, PA, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC: " BIEI ") announced today they are actively searching for a partner to develop their patented extracorporeal treatment process in [...]
Capricor to Host Key Opinion Leader Lunch on March 9
28/02/2018
LOS ANGELES, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced it will host a Key Opinion Leader Lunch in New York City on March 9 featuring four distinguished speakers to discuss [...]
Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer
28/02/2018
SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that [...]
Maple Leaf Provides Further Details on the Transfer of its Listing to the Aequitas NEO Exchange Inc.
28/02/2018
CALGARY, Alberta, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSX-V: MGW ) (OTCQB:MGWFF) is pleased to provide further information to the Company’s press release [...]
Aclaris Therapeutics to Webcast Conference Call Discussing Fourth Quarter and Full Year 2017 Financial Results on March 12, 2018
28/02/2018
WAYNE, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and [...]
Actinium Pharmaceuticals Highlights Key Activities and Progress at BMT Tandem Meetings, the Combined Annual Meetings of the Two Leading Transplant Organizations
28/02/2018
- Protocol changes to the control arm of the pivotal Phase 3 trial for Iomab-B well received at the Company’s investigator meeting and by Iomab-B’s scientific advisory board - Product theater presentations featuring [...]
Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results
28/02/2018
SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ) today announced that it will report financial results for the fourth quarter and full year ended December 31, 2017, after the [...]
Budget 2018: Ovarian cancer research funding still a concern for women
28/02/2018
Toronto, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Advocates pressing for federal investment to address ovarian cancer are today re-iterating the need for specific and targeted investments in ovarian cancer research. While [...]
Budget 2018 : Le financement de la recherche sur le cancer de l’ovaire préoccupe toujours les femmes
28/02/2018
Toronto, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Les porte-parole qui demandaient des investissements fédéraux pour lutter contre le cancer de l’ovaire réitèrent aujourd’hui la nécessité d’investissements spécifiques et [...]
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
28/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ) today announced that it is joining the global initiative to raise awareness of Rare Disease Day®, an [...]
Strongbridge Biopharma plc to Host Conference Call on March 12, 2018 to Announce Fourth Quarter and Year-End 2017 Financial Results and Provide Corporate Update
28/02/2018
DUBLIN, Ireland and TREVOSE, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Terveystalo Plc: Notice of the Annual General Meeting
28/02/2018
Terveystalo Plc, Stock Exchange Release 28 February 2018 at 2:00 PM EET Notice is given to the shareholders of Terveystalo Plc of the Annual General Meeting to be held on Thursday, 12 April 2018 at 3:00 p.m. at Marina [...]
Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency
28/02/2018
28 February 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty [...]
Lexicon Pharmaceuticals Announces Poster Presentation at the 15th Annual ENETS Conference
28/02/2018
THE WOODLANDS, Texas, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), announced today that data from a poster highlighting XERMELO ® (telotristat ethyl) will be presented at the upcoming [...]
Trevena to Host Conference Call on March 7th to Discuss Full Year 2017 Financial Results
28/02/2018
CHESTERBROOK, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will host a conference call on Wednesday, March 7, 2018 at 8:00 am EST to review financial results as of and for [...]
Melinta Therapeutics To Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018
28/02/2018
NEW HAVEN, Conn., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]

Pages